MEDBOSE 50
- Description
Product Description
COMPOSITION: Each tablet contains
Acarbose …………………………………… 50 mg
INDICATION:
– Acarbose is indicated: As monotherapy as an adjunct to diet and exercise for the management of non-insulindependent (type II) diabetes mellitus (NIDDM) in patients whose hyperglycaemia (especially postprandial hyperglycaemia) cannot be controlled by diet and exercise alone
– In combination with a sulfonylurea as an adjunct to diet and exercise for the management of type II diabetes mellitus in patients whose hyperglycaemia cannot be controlled with acarbose or sulfonylurea monotherapy.
CONTRAINDICATIONS:
– Hypersensitivity to acarbose and other ingredients of the drug.
– Intestinal infections, especially in association with ulcers.
– Because the drug has the ability to create gas in the intestine, not recommended for people prone to diseases caused by increased abdominal pressure (hernia).
– Cases of liver failure, increased liver enzymes.
– Cases of impaired renal function
– Pregnant or lactating women.
– Hypoglycemia.
– Diabetes ketoacidosis.
– Children under 18
PRESENTATION:
Box of 6 blisters x 10 film coated tablets; Box of 9 blisters x 10 film coated tablets
